The Association Between S100A12 Protein and C-Reactive Protein with Malignant Ventricular Arrhythmias Following Acute Myocardial Infarction in the Elderly

References

• Zhou Z, Liu C, Xu S, et al. Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model. Basic Res Cardiol. 2022;117(1):34. doi:10.1007/s00395-022-00939-2
   PubMed Web of Science ®Google Scholar
• Zeymer U. Hat der Patient einen Herzinfarkt? [Diagnosis and initial management of acute myocardial infarction]. MMW Fortschr Med. 2019;161(4):34–36. Gernman.
   PubMedGoogle Scholar
• Pollard TJ. The acute myocardial infarction. Prim Care. 2000;27(3):631–49;vi. doi:10.1016/S0095-4543(05)70167-6
   PubMed Web of Science ®Google Scholar
• Wang CG, Qin XC, Nie SP, Wang CM, Ai H, Que B. C-reactive protein as a predictor of malignant ventricular arrhythmias in non-ST elevation myocardial infarction. J Geriatr Cardiol. 2019;16(8):614–620. doi:10.11909/j.issn.1671-5411.2019.08.007
   PubMedGoogle Scholar
• Bui AH, Waks JW. Risk stratification of sudden cardiac death after acute myocardial infarction. J Innov Card Rhythm Manag. 2018;9(2):3035–3049. doi:10.19102/icrm.2018.090201
   PubMedGoogle Scholar
• Compiling Group of China’s Cardiovascular Health and Disease Report, Hu Shengshou. Annual report on cardiovascular health and diseases in China (2020). Chin Circ J. 2021;36(06):521–545.
   Google Scholar
• Çitaku H, Miftari R, Stubljar D, Krasniqi X. Size of acute myocardial infarction correlates with earlier time of initiation of reperfusion therapy with cardiac perfusion scintigraphy: a national single-center study. Med Sci Monit Basic Res. 2021;27:e933214. doi:10.12659/MSMBR.933214
   PubMed Web of Science ®Google Scholar
• Cai S, Zhao M, Zhou B, et al. Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction. J Clin Invest. 2023;133(4):e159498. doi:10.1172/JCI159498
   PubMed Web of Science ®Google Scholar
• Sun W, Wu Y, Gao M, et al. C-reactive protein promotes inflammation through TLR4/NF-κB/TGF-β pathway in HL-1 cells. Biosci Rep. 2019;39(8):BSR20190888. doi:10.1042/BSR20190888
   PubMedGoogle Scholar
• Wang Z, Wang B, Li X, Zhang S, Wu S, Xia Y. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: results from the Kailuan study. Nutr Metab Cardiovasc Dis. 2021;31(1):102–109. doi:10.1016/j.numecd.2020.06.026
   PubMed Web of Science ®Google Scholar
• Xie JY, Noeman M, Pimenta D, Little C. C-reactive protein as a predictor for developing post-operative atrial fibrillation. Europace. 2021;23(1):159. doi:10.1093/europace/euaa303
   PubMed Web of Science ®Google Scholar
• Kalinskaya A, Dukhin O, Lebedeva A, et al. Circulating cytokines in myocardial infarction are associated with coronary blood flow. Front Immunol. 2022;13:837642. doi:10.3389/fimmu.2022.837642
   PubMed Web of Science ®Google Scholar
• Wang L, Peng Y, Song L, et al. Colchicine-containing nanoparticles attenuates acute myocardial infarction injury by inhibiting inflammation. Cardiovasc Drugs Ther. 2022;36(6):1075–1089. doi:10.1007/s10557-021-07239-2
   PubMed Web of Science ®Google Scholar
• Alkouri A, Cybularz M, Mierke J, et al. The predictive role of early CRP values for one-year mortality in the first 2 d after acute myocardial infarction. Biomarkers. 2022;27(3):293–298. doi:10.1080/1354750X.2022.2040591
   PubMed Web of Science ®Google Scholar
• Li Y, He Y, Chen S, et al. S100A12 as biomarker of disease severity and prognosis in patients with idiopathic pulmonary fibrosis. Front Immunol. 2022;13:810338. doi:10.3389/fimmu.2022.810338
   PubMed Web of Science ®Google Scholar
• Kazakov AS, Zemskova MY, Rystsov GK, et al. Specific S100 proteins bind tumor necrosis factor and inhibit its activity. Int J Mol Sci. 2022;23(24):15956. doi:10.3390/ijms232415956
   PubMed Web of Science ®Google Scholar
• Xie J, Luo C, Mo B, et al. Inflammation and oxidative stress role of S100A12 as a potential diagnostic and therapeutic biomarker in acute myocardial infarction. Oxid Med Cell Longev. 2022;2022:2633123. doi:10.1155/2022/2633123
   PubMed Web of Science ®Google Scholar
• Xinglan C, Shengnan L, Shaofeng C, Deng F, Peiyi Z. Research progress on the relationship between S100A8/A9 and S100A12 with atherosclerosis. Hainan Med J. 2020;31(05):647–652.
   Google Scholar
• Zhiqiang N, Hongyan J, Guokang Y, Han L, Bin X. Expression and prognostic value of S100A12, ABI, and non-HDL-C in coronary atherosclerotic heart disease. Med Pharm J Chin People’s Lib Army. 2021;33(08):66–69+91.
   Google Scholar
• Singh H, Rai V, Agrawal DK. LPS and oxLDL-induced S100A12 and RAGE expression in carotid arteries of atherosclerotic Yucatan microswine. Mol Biol Rep. 2022;49(9):8663–8672. doi:10.1007/s11033-022-07703-8
   PubMed Web of Science ®Google Scholar
• Selcuk M, Cinar T, Saylik F, Dogan S, Selcuk I, Orhan AL. Predictive value of systemic immune inflammation index for postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting. Meden Med J. 2021;36(4):318–324. doi:10.4274/MMJ.galenos.2021.37998
   PubMedGoogle Scholar
• Bağcı A, Aksoy F. Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction. Biomarker Med. 2021;15(10):731–739. doi:10.2217/bmm-2020-0838
   PubMed Web of Science ®Google Scholar
• Stengaard C, Sørensen JT, Rasmussen MB, Bøtker MT, Pedersen CK, Terkelsen CJ. Prehospital diagnosis of patients with acute myocardial infarction. Diagnosis. 2016;3(4):155–166. doi:10.1515/dx-2016-0021
   Google Scholar
• Wu W, He J, Zhang S, Zeng C, Wang Q. Basic demographic characteristics and prevalence of comorbidities in acute mesenteric ischemia: a systematic review and proportional meta-analysis. Scand J Gastroenterol. 2023;58(6):605–618. doi:10.1080/00365521.2022.2152289
   PubMed Web of Science ®Google Scholar
• Takada T, Shishido K, Hayashi T, et al. Impact of late ventricular arrhythmias on cardiac mortality in patients with acute myocardial infarction. J Interv Cardiol. 2019;2019:5345178. doi:10.1155/2019/5345178
   PubMed Web of Science ®Google Scholar
• Oikawa J, Fukaya H, Ako J, et al; on behalf the J-MINUET Investigators. Risk factors of in-hospital lethal arrhythmia following acute myocardial infarction in patients undergoing primary percutaneous coronary intervention- insight from the J-MINUET study. Circ Rep. 2019;2(1):17–23. doi:10.1253/circrep.CR-19-0081
   PubMedGoogle Scholar
• Ren L, Guo J, Zhao W, et al. Serum homocysteine relates to elevated lipid level, inflammation and major adverse cardiac event risk in acute myocardial infarction patients. Biomarker Med. 2023;17(6):297–306. doi:10.2217/bmm-2023-0096
   PubMed Web of Science ®Google Scholar
• Zhang N, Shi F, Liang H, Wang H. The feasibility of using Hcy, CRP, and Cys-C to analyze AMI patients’ disease conditions and prognoses. Am J Transl Res. 2021;13(4):2724–2730.
   PubMed Web of Science ®Google Scholar
• Nurmohamed NS, Belo Pereira JP, Hoogeveen RM, et al. Targeted proteomics improves cardiovascular risk prediction in secondary prevention. Eur Heart J. 2022;43(16):1569–1577. doi:10.1093/eurheartj/ehac055
   PubMed Web of Science ®Google Scholar
• Sheriff A, Kayser S, Brunner P, Vogt B. C-reactive protein triggers cell death in ischemic cells. Front Immunol. 2021;12:630430. doi:10.3389/fimmu.2021.630430
   PubMed Web of Science ®Google Scholar
• Maier W, Altwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation. 2005;111(11):1355–1361. doi:10.1161/01.CIR.0000158479.58589.0A
   PubMed Web of Science ®Google Scholar
• Oprescu N, Micheu MM, Scafa-Udriste A, Popa-Fotea NM, Dorobantu M. Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease. Ann Med. 2021;53(1):1041–1047. doi:10.1080/07853890.2021.1916070
   PubMed Web of Science ®Google Scholar
• Akbarzadeh Najar R, Ghaderian SM, Tabatabaei Panah AS. C-reactive protein (CRP) gene polymorphisms: implication in CRP plasma levels and susceptibility to acute myocardial infarction. Mol Biol Rep. 2012;39(4):3705–3712. doi:10.1007/s11033-011-1145-z
   PubMed Web of Science ®Google Scholar
• Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104(24):2886–2891. doi:10.1161/hc4901.101760
   PubMed Web of Science ®Google Scholar
• Asadikaram G, Noroozi S, Ebrahimi Meimand HA, et al. Interferon-β 1a modulates expression of RAGE but not S100A12 and nuclear factor-κB in multiple sclerosis patients. Neuroimmunomodulation. 2016;23(5–6):345–351. doi:10.1159/000464136
   PubMed Web of Science ®Google Scholar
• Kim K, Kim HJ, Binas B, Kang JH, Chung IY. Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells. Biochem Biophys Res Commun. 2018;503(2):657–664. doi:10.1016/j.bbrc.2018.06.057
   PubMed Web of Science ®Google Scholar
• He YY, Yan W, Liu CL, et al. Usefulness of S100A12 as a prognostic biomarker for adverse events in patients with heart failure. Clin Biochem. 2015;48(4–5):329–333. doi:10.1016/j.clinbiochem.2014.11.016
   PubMed Web of Science ®Google Scholar
• Tong X, Zhao X, Dang X, Kou Y, Kou J. Predicting diagnostic gene biomarkers associated with immune checkpoints, N6-methyladenosine, and ferroptosis in patients with acute myocardial infarction. Front Cardiovasc Med. 2022;9:836067. doi:10.3389/fcvm.2022.836067
   PubMed Web of Science ®Google Scholar
• Gellen B, Thorin-Trescases N, Thorin E, et al; SURDIAGENE Study group. Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes. ESC Heart Fail. 2022;9(6):3909–3919. doi:10.1002/ehf2.14036
   PubMed Web of Science ®Google Scholar
• Xiaotong L, Xin L, Xue W, Wei S, Shanshan X, Laichuan L. Relationship between serum S100A12 levels and severity of coronary artery lesions in AMI patients. J Clin Cardiol. 2018;34(06):588–592.
   Google Scholar